Legal Representation
Attorney
Eric Lamb
USPTO Deadlines
Next Deadline
64 days remaining
NOA E-Mailed - SOU Required
Due Date
April 15, 2026
Extension Available
Until October 15, 2026
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 30, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 29, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Sep 29, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Sep 29, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 15, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 18, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 18, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 12, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 24, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 9, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 9, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 9, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 14, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 14, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 14, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 8, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 15, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 15, 2024 | TAEA | I | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | Loading... |
| May 15, 2024 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| May 6, 2024 | TAEA | I | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | Loading... |
| May 6, 2024 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Apr 24, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 040
Custom assembling of materials for others, namely, custom assembling of antibody drug conjugates and intermediates thereof; custom manufacturing of pharmaceuticals; custom manufacturing of drug conjugates; custom production of pharmaceuticals; custom production of biological preparations; custom manufacturing of Antibody-drug Conjugates; custom manufacturing of chemical reagents; custom manufacturing of pharmaceutical preparations; custom manufacturing of biomedical preparations; custom manufacture of drug conjugates; processing of pharmaceutical preparations; processing or treating of chemical reagents; processing of antibody drugs; custom manufacturing of Antibody drugs; processing of biomedical preparations; processing of biotechnology drug;
Class 042
Development of products for others in the field of pharmaceuticals; pharmaceutical drug development services; research and development of new products in the field of pharmaceuticals; biochemical research and development; custom design and development of chemical reagent antibodies and conjugate antibodies; research and development in the pharmaceutical, biomedicine and biotechnology fields; research and development of antibodies; research and development of conjugated antibodies; biomedical research services; development of pharmaceutical preparations and medicines; research and development of antibody-drug conjugates; research and development of drug conjugates; preclinical research and evaluation of new drugs; technology product development consulting services; research and development of new products for others; scientific research and development
Classification
International Classes
040
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"TECH"